| Title | Critical Reviews in Therapeutic Drug Carrier Systems |
| Abbreviation | Crit. Rev. Ther. Drug Carr. Syst. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3) |
| h-index | 79 |
| Overall Rank/Ranking | 12025 |
| SCImago Journal Rank (SJR) | 0.420 |
| Impact Score | 3.00 |
| Publisher | Begell House Inc. |
| Country | United States |
| ISSN | 07434863, 2162660X |
| Best Quartile | Q2 |
| Coverage History | 1984-2023 |
Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields.
Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science.
Critical Reviews in Therapeutic Drug Carrier Systems is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3). It is published by Begell House Inc.. The overall rank of Critical Reviews in Therapeutic Drug Carrier Systems is 12025. According to SCImago Journal Rank (SJR), this journal is ranked 0.420. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 79. The best quartile for this journal is Q2.
The ISSN of Critical Reviews in Therapeutic Drug Carrier Systems journal is 07434863, 2162660X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Critical Reviews in Therapeutic Drug Carrier Systems is cited by a total of 172 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Critical Reviews in Therapeutic Drug Carrier Systems is 3.00, which is computed in 2023 as per its definition. Critical Reviews in Therapeutic Drug Carrier Systems IF is decreased by a factor of 0.45 and approximate percentage change is -13.04% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Critical Reviews in Therapeutic Drug Carrier Systems is 3.00. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.00 |
| 2021 | 3.45 |
| 2020 | 4.85 |
| 2019 | 2.17 |
| 2018 | 2.90 |
| 2017 | 2.90 |
| 2016 | 7.00 |
| 2015 | 5.67 |
| 2014 | 5.07 |
Critical Reviews in Therapeutic Drug Carrier Systems has an h-index of 79. It means 79 articles of this journal have more than 79 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Critical Reviews in Therapeutic Drug Carrier Systems is 07434863, 2162660X. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Critical Reviews in Therapeutic Drug Carrier Systems is 12025. According to SCImago Journal Rank (SJR), this journal is ranked 0.420. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.420 |
| 2021 | 0.473 |
| 2020 | 0.730 |
| 2019 | 0.639 |
| 2018 | 0.736 |
| 2017 | 0.573 |
| 2016 | 0.706 |
| 2015 | 1.164 |
| 2014 | 1.137 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 12025 |
| 2021 | 10524 |
| 2020 | 6764 |
| 2019 | 7713 |
| 2018 | 6493 |
| 2017 | 8210 |
| 2016 | 6693 |
| 2015 | 3566 |
| 2014 | 3589 |
Critical Reviews in Therapeutic Drug Carrier Systems is published by Begell House Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1984-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Critical Reviews in Therapeutic Drug Carrier Systems is Crit. Rev. Ther. Drug Carr. Syst.. This abbreviation ('Crit. Rev. Ther. Drug Carr. Syst.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Critical Reviews in Therapeutic Drug Carrier Systems latest impact IF is 3.00. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 7.00 (2016) and 2.17 (2019), respectively, in the last 9 years. Moreover, its average IS is 4.11 in the previous 9 years.
The Critical Reviews in Therapeutic Drug Carrier Systems has an SJR (SCImago Journal Rank) of 0.420, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.164 in 2015 and the lowest being 0.420 in 2022. Furthermore, the average SJR of the Critical Reviews in Therapeutic Drug Carrier Systems over the previous 9-year period stands at 4.11.
The latest h-index of the Critical Reviews in Therapeutic Drug Carrier Systems is 79.
The Critical Reviews in Therapeutic Drug Carrier Systems is published by the Begell House Inc., with its country of publication being the United States.
The Critical Reviews in Therapeutic Drug Carrier Systems is currently ranked 12025 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 3566 in 2015 and its lowest position of 12025 in 2022.
The standard ISO4 abbreviation for the Critical Reviews in Therapeutic Drug Carrier Systems is Crit. Rev. Ther. Drug Carr. Syst..
Critical Reviews in Therapeutic Drug Carrier Systems is classified as a journal that the Begell House Inc. publishes.
The Critical Reviews in Therapeutic Drug Carrier Systems encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Critical Reviews in Therapeutic Drug Carrier Systems is assigned the following International Standard Serial Numbers (ISSN): 07434863, 2162660X.
The best quartile for the Critical Reviews in Therapeutic Drug Carrier Systems is Q2 (2022).
The Critical Reviews in Therapeutic Drug Carrier Systems coverage history can be summarized as follows: 1984-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Business: Theory and Practice | journal | 13414 | Vilnius Gediminas Technical University | 21 | 2.47 |
| Journal of Field Archaeology | journal | 5639 | Maney Publishing | 43 | 2.38 |
| Journal of Competition Law and Economics | journal | 14815 | Oxford University Press | 29 | 0.72 |
| Journal of International Financial Management and Accounting | journal | 6179 | Wiley-Blackwell Publishing Ltd | 42 | 6.09 |
| Journal of Supply Chain Management | journal | 378 | Wiley-Blackwell | 104 | 12.58 |
| Discourse | journal | 6621 | Routledge | 59 | 2.11 |
| International Journal of Applied Linguistics | journal | 7321 | Wiley-Blackwell Publishing Ltd | 51 | 2.00 |
| Transnational Corporations | journal | 6120 | UNCTAD United Nations Conference on Trade and Development | 27 | 1.92 |
| Population Review | journal | 17841 | Sociological Demography Press | 13 | 0.73 |
| Indian Phytopathology | journal | 14222 | Springer Nature | 11 | 1.33 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.00 |
| 2021 | 3.45 |
| 2020 | 4.85 |
| 2019 | 2.17 |
| 2018 | 2.90 |
| 2017 | 2.90 |
| 2016 | 7.00 |
| 2015 | 5.67 |
| 2014 | 5.07 |
